3002.15.00.11 - Containing monoclonal antibodies 🖩

This HTS category, 3002.15.00.11, specifically covers immunological products that are presented in measured doses or in forms or packings suitable for retail sale, and critically, contain monoclonal antibodies. These are highly specific biological agents designed to target particular antigens, often used in advanced therapeutic and diagnostic applications. The "measured doses" aspect refers to pre-packaged units for administration, while "forms or packings for retail sale" indicates they are intended for direct purchase by end-users or healthcare providers without further processing.

The primary distinction of this subcategory from its sibling, 3002.15.00.91 ("Other"), lies in the presence of monoclonal antibodies. While both fall under immunological products prepared for retail sale, 3002.15.00.11 is narrowly defined to include only those products incorporating these specific, highly targeted antibody types. Other immunological products at this level, classified under 3002.15.00.91, would encompass a broader range of immune-related preparations that do not specifically contain monoclonal antibodies, such as polyclonal antibodies, certain diagnostic kits not primarily based on monoclonal antibodies, or other non-antibody-based immunological agents.

As this HTS code represents a leaf node, there are no further subcategories. The classification is definitive for immunological products in measured doses or retail packaging that are identified as containing monoclonal antibodies. Examples would include specific therapeutic monoclonal antibody injections, diagnostic kits that rely on monoclonal antibodies for antigen detection, and other similar preparations intended for direct use in healthcare settings or by consumers. Careful attention should be paid to the product's composition and intended use to ensure correct classification under this specific code.